Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Stage at diagnosis and ovarian cancer survival: evidence from the International Cancer Benchmarking Partnership

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Antiemetic use of olanzapine in patients with advanced cancer: results from an open-label multicenter study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The nature of nausea: prevalence, etiology, and treatment in patients with advanced cancer not receiving antineoplastic treatment

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Guideline vedrørende kirurgisk behandling af UI

    Publikation: AndetUdgivelser på nettet - Net-publikationUndervisning

Vis graf over relationer
Age is associated with poor prognosis in ovarian cancer patients. Reasons could be increased comorbidity, more advanced stage, or nonoptimal surgery or chemotherapy. Objectives of this study were to evaluate the significance of comorbidity and age ≥70 years on receiving cytoreductive surgery, standard combination chemotherapy (TC), adherence to TC treatment, and prognosis.
OriginalsprogEngelsk
TidsskriftJournal of Gynecologic Oncology Nursing
Vol/bind127
Udgave nummer2
Sider (fra-til)367-74
Antal sider8
ISSN1536-9935
DOI
StatusUdgivet - 2012

ID: 36904771